ER Niacin

extended-release niacin · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ER Niacin, covering 2009-02-05 to 2019-10-08. Get the full timeline:

Most recent: Clinical Trial Update: ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART [Phase 4]

See pricing